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Abstract Prevention researchers have advocated primary
prevention such as vaccination in alternative venues.
However, there have been major questions about both the
attendance of, and the ability to, vaccinate high-risk
individuals in such settings. The current study seeks to
assess the feasibility of vaccinating high-risk men who have
sex with men (MSM) at Gay Pride events. The research
questions are: Do gay men who are sampled at Gay Pride
events engage in more or less risky behavior than gay men
sampled at other venues? Do the gay men who receive
hepatitis vaccinations at Gay Pride engage in more or less
risky behavior than gay men at Gay Pride who do not
receive hepatitis vaccination? Of the 3689 MSM that
completed the Field Risk Assessment (FRA), 1095/3689=
29.68% were recruited at either the 2006 or 2007 Long
Beach, California Gay Pride events. The remaining, 2594/
3689=70.32% were recruited at Long Beach gay bars, gay
community organizations and institutions, and through
street recruitment in various gay enclaves in the Long
Beach area. Logistic regression analysis yielded eight
factors that were associated with non-attendance of Gay
Pride: Age, had sex while high in the last 12 months, had
unprotected anal intercourse (UAI) in the last 12 months,
had sex for drugs/money in the last 12 months, been
diagnosed with a sexually transmitted infection (STI) in the
last 12 months, used nitrites (poppers) in the last 12 months,
and used methamphetamine in the last 12 months. Identifying
as White, Asian, or African American compared to Hispanic
was also associated with non-attendance. Bivariate analysis
indicated that, of the MSM sampled at Gay Pride, 280/1095=
25.57% received a hepatitis vaccination there. The MSM
sampled at Gay Pride who reported engaging in UAI or
having used any stimulant (cocaine, crack-cocaine, or
methamphetamine) in the last 12 months were more likely
to receive hepatitis vaccination on-site. The results provide
evidencefortheviabilityofsuccessfullyvaccinatinghigh-risk
MSM at Gay Pride events. However, it is vital that no-cost
vaccinationsare alsofundedinother communitysettingssuch
as STI clinics, drug treatment programs, prisons, universities,
and other community resource centers in order to reach those
additional high-risk MSM who do not attend Gay Pride.
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Introduction
U.S. rates of the hepatitis Avirus (HAV) and hepatitis B virus
(HBV) have been steadily dropping since the introduction of
the HAV and HBV vaccines in 1995 and 1982 respectively
(Bondesson and Saperston 1996). Unfortunately, this decline
has excluded men who have sex with men (MSM) (Levine
2003a; MacKellar et al. 2001). According to the Centers for
Disease Control and Prevention (CDC; 2006a, 2006b),
MSM account for 10% of new HAV cases and 15 to 20%
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DOI 10.1007/s11121-009-0164-7of new HBV cases each year. This is particularly alarming
considering that MSM constitute only 8% of the U.S. male
population and that less than half of all MSM in the U.S.
have received either the HAV or HBV vaccine (Diamond et
al. 2003). In one study of hepatitis vaccination in New York
City, only 70% of gym-attending gay men reported having
been vaccinated for HBV (Siconolfi et al. 2009).
Oral-anal contact or “rimming” places MSM at heightened
risk for acquiring HAV which is spread through fecal-oral
contact (Jacobsen and Koopman 2004; Mazick et al. 2005).
HBV is transmitted among MSM through high-risk sexual
behavior such as unprotected anal intercourse (UAI) that
results in the sharing of blood or semen (Ostrow et al. 1999;
Seage et al. 1997; Szmuness et al. 1975). Drugs that have
been shown to impair judgment such as cocaine, crack-
cocaine, and methamphetamine, have been linked to higher
rates of UAI among MSM (Appleby et al. 2007;C o l f a xe ta l .
2005; Fisher et al. 2009;H a l k i t i se ta l .2006; Hirshfield et al.
2004;S e m p l ee ta l .2002; Springer et al. 2007). Because
engaging in high-risk behaviors places MSM at elevated risk
for contracting HAV and HBV, it is paramount that
vaccinations are made readily available and promoted among
this high-risk group.
Identifying the gaps in both HAV and HBV vaccine
coverage among high-risk MSM is essential for targeting
the delivery of an effective vaccine. Once the gaps have
been identified, the question that follows is: What is the best
approach to reach these high-risk MSM for vaccination?
Traditionally, the majority of MSM who have received HAV
and HBV vaccinations have used a regular source of health
care such as a private physician, school, hospital or
community health clinic (Alter et al. 1990; MacKellar et al.
2001;M c C u s k e re ta l .1990; Rabeneck et al. 1993).
Unfortunately, this results in only 1 in 10 MSM at risk for
HAVand HBV infection receiving vaccination (MacKellar et
al. 2001). MSM are not being educated about the risks
associated with HAV and HBV, nor are suggestions for
vaccination being made on a regular basis in these health
care settings (Diamond et al. 2003;G u n ne ta l .2001; Kahn
2002). This is despite a major public service announcement
campaign that was aimed at those at high risk of hepatitis
including gay men (MacDougall 1998). One possible
explanation for the lack of vaccination is that many MSM
do not disclose their sexual orientation to their primary care
providers and, as a result, the providers are not aware of the
elevated risk to their patients (Betts 2002; MacKellar et al.
2001; Martinson et al. 1996).
Public health researchers have advocated hepatitis
vaccine service delivery in alternative venues (Des Jarlais
et al. 2001; Trubatch et al. 2000); however, there has been a
major question about the willingness of high-risk MSM to
be vaccinated in such settings. One alternative venue for
accessing MSM for vaccination is through local Gay Pride
events (Allard et al. 2001). Gay Pride is a locally organized
festival that takes place in over 100 cities around the U.S.
each year (Kates and Belk 2001). Long Beach, California is
one of the cities that holds a Gay Pride event. As stated in
the City’s Consolidated Plan, Long Beach is considered to
be the most ethnically diverse major city in the United States.
The racial /ethnic composition in Long Beach as of the 2000
Census,isasfollows:33%White,36%Hispanic,15%African
American, 13% Asian, and other racial groups represent the
remaining 3% of the population. The percentage of Hispanics
has been increasing in recent years. The Long Beach Gay
Pride is the second largest in California after San Francisco.
Gay Pride events in other cities have been successfully
utilized for sampling MSM populations for research, Human
Immunodeficiency Virus (HIV)-prevention education, HIV
rapid testing, and other health-promotion efforts (Brennan et
al.2007; Eaton et al. 2007; Gallagher et al. 2007;K a l i c h m a n
et al. 2004). One advantage to using Gay Pride events is the
ability to capture MSM who may not disclose their high-risk
behaviors to their health care providers (Levine 2003a).
There is a need to understand the factors that would facilitate
and optimize hepatitis vaccination programs (Levine 2003b).
However, one must first ask the questions: (a) Are those men
who go to gay bars and other gay venues, different from
those who attend Gay Pride? and (b) Are those high-risk
MSM who attend Gay Pride reached by an on-site
vaccination effort? The current study will contribute to this
understanding by describing the predictors of Gay Pride
attendance among MSM and then describing the successful
vaccination of high-risk MSM for HAVand HBVat two Gay
Pride events.
Methods
Participants
Atotalof3689MSMwererecruitedforthe currentstudy.The
eligibility requirement for participation was identifying as
male and reporting having had sex with a man in the last
5 years. The majority (n=2594) of MSM were recruited
through gay bars and organizations, and street recruitment in
various gay enclaves in the Long Beach, California area.
These MSM were administered a brief Field Risk Assess-
ment (FRA) interview at the recruitment site and were then
referred to the Center for Behavioral Research and Services
(CBRS) in Long Beach for participation in an individual-
level sexually transmitted infection (STI)/HIV risk-reduction
program. The remaining 1095 MSM were recruited at either
the 2006 or 2007 Long Beach Gay Pride events. The Gay
Pride participants initially completed the brief FRA and were
then referred to the CBRS’ vaccination station for the HAV
and HBV vaccinations located on site at Gay Pride. Table 1
220 Prev Sci (2010) 11:219–227demonstrates the age and ethnic distribution of MSM
recruited at Gay Pride versus those recruited at locations
other than Gay Pride.
Measures
The Field Risk Assessment (FRA), a 36-item structured
interview, was used for assessment of the MSM’s demo-
graphics as well as their reported drug use and sexual
behavior (Kochems et al. 2008).
Vaccination Procedures
Participants at Gay Pride were approached by outreach
workers from CBRS and Hep Team Los Angeles and
offered the combined HAV/HBV vaccine (TWINRIX®,
GlaxoSmithKline). After providing documentation that they
were at least 18 years old and signing the informed consent
form, the FRA questionnaire was administered by CBRS
outreach staff. After completing the FRA, the participant was
then shown to the vaccination station. The vaccination station
was staffed with one volunteer physician, one volunteer nurse
practitioner, and several volunteer registered nurses. There,
the nurse (or physician) assessed for any contraindications for
the vaccinations, reviewed the informed consent form, and
provided the vaccine information sheets as per CDC guide-
lines; this took approximately 5–15 min. After reconfirming
the participant’s intention to obtain the HAV/HBV vaccine,
the nurse administered the hepatitis adult vaccines via
intramuscular route as stated in the product package insert
recommendations.
After injection, the participant was reminded of the need to
return for the second dose one month after the first dose and
for the third dose, six months after the first. Participants were
provided with reminder cards of the recommended vaccine
schedule, which they addressed to themselves at the address
of their choice. These reminder cards were then retained by
the nurse for mailing about one week prior to the time that the
participant would be due for the 2nd dose of vaccine. No
participant experienced any reactions or adverse events that
would constitute a contraindication during the two days of
either the 2006 or the 2007 Pride event.
Table 1 Bivariate analysis of gay pride attendance among MSM (N=3689)
Pride (n=1095) No Pride (n=2594)
Demographics
Variable M (SD) M (SD) t(3689)
Age 34.26 (10.63) 37.53 (10.55) 8.56
**
Variable n (%) n (%) χ
2(1)
Ethnicity:
Hispanic 494 (45.11) 685 (26.40) 125.76
***
White 409 (37.35) 1216 (46.89) 27.48
***
African American 76 (6.94) 401 (15.46) 49.21
***
Asian 43 (3.93) 144 (5.53) NS
Other 73 (6.67) 148 (5.72) NS
Homeless 35 (3.21) 404 (15.79) 114.31
***
Sexual risk behavior
Had sex while high in last 12 months 190 (17.35) 869 (33.50) 96.57
***
Had UAI in last 12 months 480 (43.84) 1580 (60.91) 88.58
***
Had sex for drugs/money in last 12 months 23 (2.10) 208 (8.02) 45.69
***
Diagnosed with STI in last 12 months 28 (2.56) 186 (7.17) 29.69
***
Drug use behavior
Used methamphetamine in last 12 months 64 (5.84) 547 (21.09) 128.40
***
Used crack-cocaine in last 12 months 21 (1.92) 230 (8.87) 58.20
***
Used nitrites in last 12 months 42 (3.84) 300 (11.57) 54.07
***
Used Viagra® in last 12 months 81 (7.40) 339 (13.07) 24.21
***
Shared needles in last 12 months 12 (1.10) 108 (4.16) 22.82
***
Used cocaine in last 12 months 46 (4.20) 219 (8.44) 20.49
***
Used inhalants in last 12 months 15 (1.37) 84 (3.24) 10.13
*
Used GHB in last 12 months 18 (1.64) 83 (3.20) 6.88
*
*p<.01,
**p<.001,
***p<.0001
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Data were entered in Viking Data Entry and Images version
4.2 (Viking Software Solutions 2001). Analysis was then
conducted in SAS version 9.1.3 service pack 4 on a Windows
2003 server. To understand the characteristics of those
attending Gay Pride, we constructed a logistic regression
model predicting Gay Pride attendance. To describe the
success of the vaccination efforts, bivariate analyses were
used to determine the relationship between participant
high-risk behavior and receipt of hepatitis vaccination.
Results
Table 1 presents the bivariate analysis of Gay Pride
attendance among the overall sample of MSM. The analysis
demonstrates a consistent pattern of sexual risk behavior and
drug use behavior being associated with non-attendance
at Gay Pride. Methamphetamine, crack-cocaine, nitrites
(poppers), and Viagra® were especially prevalent in the
analysis.
Table 2 shows the logistic regression model predicting
Gay Pride attendance for the overall sample of MSM. The
analysis yields a predictive model of eight factors that are
associated with non-attendance at Gay Pride. These factors
are associated with age, ethnicity, drug use, and high-risk
sexual behavior as indicated by negative coefficients and
odds ratios of less than one.
Table 3 provides bivariate analyses indicating that, of the
MSM sample who were recruited at Gay Pride, 280/1095=
25.57% (CI.95 = 23.01, 28.26) received a hepatitis
vaccination. Interestingly, the MSM who reported engaging
in UAI in the last 12 months were significantly more likely
to have been vaccinated at Gay Pride. Also, the MSM who
reported using illicit stimulants (cocaine, crack-cocaine, or
methamphetamine) in the last 12 months were also signifi-
cantly more likely to have obtained a hepatitis vaccination at
Gay Pride. The other variables that were included in Table 1
are also included in Table 3 for comparison purposes. Most
of these other variables, including ethnicity and age of
participants, were not significantly associated with hepatitis
vaccination.
Discussion
This study’s major findings are twofold. First, Gay Pride
events were demonstrated to be a useful venue for
vaccinating MSM at high-risk for contracting HAV and
HBV. That is to say that the MSM who engage in high-risk
behavior, those using illicit drugs and engaging in UAI, are
more likely to get vaccinated than other attendees at a Gay
Pride event. The second finding suggests that while
recruitment of high-risk MSM for HAVand HBV vaccination
was achieved at several Gay Pride events, many MSM who
are at an elevated risk for HAVand HBV, those engaging in
evenhigherratesofUAI,sexwhilehigh,illicitdruguse,those
trading sex for drugs or money, and those diagnosed with an
STI in the last 12-months are not attending such events and
that additional vaccination venues are needed to adequately
target those gay men at higher risk than those who attend Gay
Pride events.
The use of methamphetamine, nitrites, and Viagra® has
been associated with higher rates of UAI among MSM
(Crosby et al. 1996; Dolezal et al. 2000;F i s h e re ta l .1992;
Mansergh et al. 2006; Parsons et al. 2003;S c h w a r c ze ta l .
2007; Spindler et al. 2007). Research has shown that MSM
Table 2 Overall analysis predicting gay pride attendance among MSM (N=3689)
Variable B SE B OR 95% CI
Ethnicity: Hispanic (ref.)
Other −.26 .17 .77 .56, 1.07
White −.61 .09 .54 .46, .64
Asian −1.00 .19 .37 .25, .53
African American −1.11 .15 .33 .25, .44
Age −.02 .004 .81 .75, .87
Had sex while high in last 12 months −.34 .10 .71 .58, .87
Had UAI in last 12 months −.40 .08 .67 .57, .78
Had sex for drugs/money in last 12 months −.54 .24 .58 .36, .93
Diagnosed with STI in last 12 months −.66 .22 .52 .34, .80
Used nitrites in last 12 months −.81 .18 .45 .31, .63
Used methamphetamine in last 12 months −.97 .15 .38 .28, .51
Hosmer-Lemeshow χ
2(8)=5.3329, p=.7215
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significantly higher prevalence of HBV infection (Drumright
et al. 2007;F i s h e re ta l .2009). The current study found that
rates of methamphetamine, nitrites, and Viagra® use were
higher among those MSM who did not attend Gay Pride
indicating that Gay Pride, even though it is a useful and
feasible vaccination venue, will not adequately target the gay
men at highest risk of hepatitis.
One possible explanation for the riskiest MSM not
attending Gay Pride may be directly related to socio-
economic status. The 2006 and 2007 Long Beach Gay
Pride event cost attendees $20 per day for admittance.
Given that many of the persons at greatest risk for infection
also have financial difficulties that may or may not be
related to their risk behavior, these individuals may have
found the admittance fee to be unduly burdensome and an
impediment to Gay Pride attendance (Jin et al. 2004;
Ostrow et al. 1999). The Gay Pride attendance fee likely
prevented some high-risk MSM at lower income levels
from attending.
Another possible explanation may be more social in
nature. Many MSM do not openly identify as gay or
bisexual for various reasons. We speculate that those who
do not identify as gay or bisexual may also be less likely to
attend events that are described as catering specifically to
gay and bisexual participants. Further, some MSM identify
as heterosexual, or are inconsistent in their sexual identity,
even though they have sex with men and are at higher risk,
for HIV and presumably HBV, than those who are
consistent in their identity (Washington et al. 2006). These
MSM have been reported to be a challenge for HIV
prevention programs and may be especially difficult to
Table 3 Bivariate analysis of gay pride vaccination among MSM (N=1095)
Vaccination (n=280) No vaccination (n=815)
Demographics
Variable M (SD) M (SD) t(1095)
Age 34.58 (10.64) 34.15 (10.63) NS
Age n (%) n (%) χ
2(1)
Ethnicity:
Hispanic 136 (48.57) 358 (43.93) NS
White 99 (35.36) 310 (38.04) NS
African American 14 (5.00) 62 (7.61) NS
Asian 23 (8.21) 58 (7.12) NS
Other 8 (2.86) 27 (3.30) NS
Housing
Homeless 11 (3.96) 24 (2.96) NS
Sexual risk behavior
Has sex while high in last 12 months 57 (20.43) 133 (16.30) NS
Had UAI in last 12 months 139 (49.64) 341 (41.84) 5.22
*
Had sex for drugs/money in last 12 months 2 (0.72) 21 (2.57) NS
Diagnosed with STI in last 12 months 10 (3.58) 18 (2.21) NS
Drug use behavior
Used methamphetamine in last 12 months 18 (6.45) 46 (5.64) NS
Used crack-cocaine in last 12 months 5 (1.79) 16 (1.96) NS
Used nitrites in last 12 months 9 (3.23) 33 (4.05) NS
Used Viagra® in last 12 months 22 (7.86) 59 (7.23) NS
Shared needles in last 12 months 2 (0.72) 10 (1.23) NS
Used cocaine in last 12 months 17 (6.09) 29 (3.55) NS
Use inhalants in last 12 months 5 (1.79) 10 (1.23) NS
Used GHB in last 12 months 6 (2.15) 12 (1.47) NS
Used any stimulant in last 12 months 35 (12.50) 66 (8.10) 4.85
*
*p<.05
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that was offered because they may be less likely to attend a
Gay Pride event that so clearly advertises an identity they
may not be comfortable embracing (Goldbaum et al. 1998).
Even though these MSM may not identify as gay or
bisexual, they may be at an elevated risk for HAVand HBV
because of possible high rates of sex and drug using
behavior (Washington et al. 2006). These men would also
benefit greatly from no-cost hepatitis vaccination (Wohl et
al. 2002).
The current study found that MSM who attended Gay
Pride in Long Beach, California were more likely to be
Hispanic than White, African American, or Asian. A recent
assessment found that, of 11 Gay Pride events in 9 U.S.
cities from 2004 to 2006, most of the events were attended
primarily by MSM who identified as an ethnic minority
(Centers for Disease Control and Prevention 2007). This
finding parallels the findings at the Long Beach, California
Gay Pride events, given the influx of Hispanics to Southern
California (Suro and Singer 2001). Conversely, the respec-
tive shortage of Hispanics sampled at venues other than
Gay Pride can be partially explained by the fact that our
outreach team during this study’s years was made up of
men who identified as African American, Asian, and White,
with limited Spanish speaking proficiency, and hence the
Gay Latino venues proved to be more challenging
recruitment sites. It has been well established in the
literature that Hispanics are at highest risk for hepatitis A
(Hayes-Bautistia et al. 2005; Saab et al. 2005; Wise and
Sorvillo 2005). The implication of this finding is that Gay
Pride is an excellent opportunity to vaccinate Hispanic gay
men for hepatitis A. The fact that we vaccinated for both
hepatitis A and hepatitis B also takes into account that there
is an association between these two diseases in Los Angeles
County (Fisher et al. 2006), and that vaccinating for both
instead of just one has been found to be cost effective
(Jacobs et al. 2004).
Age was another factor that influenced Gay Pride
attendance. MSM recruited at Gay Pride were younger on
average than MSM recruited among other venues. This
finding is consistent with previous research that has
indicated younger MSM were more likely to attend Gay
Pride (Friedman et al. 2000; Gallagher et al. 2007). This
finding is likely influenced in part by the 21-year-old
minimum age requirement for attending the Long Beach
bars and clubs where many MSM were recruited. The Long
Beach Gay Pride events did not have minimum age
requirements and subsequently the outreach team was able
to access younger MSM.
The question for prevention researchers now becomes:
What is the optimal overall strategy to vaccinate high-risk
MSM? Previous research has demonstrated successful
hepatitis vaccination of injection drug users at syringe
exchange sites (Altice et al. 2005; Des Jarlais et al. 2001).
Vaccination services have also been successfully demon-
strated at drug rehabilitation programs (Gunn et al. 2005),
prisons (Sutton et al. 2005), university health services
(Neighbors et al. 1999), STI clinics, and various other
community health organizations (Gunn et al. 2007; Sansom
et al. 2003; Trubatch et al. 2000). These avenues may be
alternative ways of reaching high-risk MSM who do not
attend Gay Pride events or openly disclose their sexual
behaviors. Several studies also underscore the major role
promotional messages in the gay media have played both in
raising awareness and facilitating referral of MSM to health
care organizations for hepatitis vaccination (Friedman et al.
2000; Warwick et al. 2007).
CBRS vaccinated the maximum number of MSM
possible at Gay Pride. However, due to funding constraints,
the number of vaccinations provided did not meet the need
of all MSM who desired vaccination. Therefore, while
25.57% of the MSM sampled at Gay Pride were vaccinated,
the authors suggest that more MSM would have been
vaccinated had the resources been available. This is similar
to the resource limitation for HIV testing at Gay Pride events
that has been pointed out by the CDC (2007). The HAV/
HBV combined vaccination that was administered at the
2006 and 2007 Long Beach Gay Pride events was the first of
a three-shot series that also includes 30-day and 6-month
administrations. Future research should address the rates at
which MSM vaccinated at Gay Pride events adhered to their
complete vaccination schedule (Rhodes and Diclemente
2003), as the number who received the first of the hepatitis
vaccination series does not represent those who completed
the series (Des Jarlais et al. 2001; Trubatch et al. 2000).
Limitations
One limitation of the current study is that measurement of
adherence to the remainder of the vaccination schedule
among those recruited and initially vaccinated at Gay Pride
was not possible. A second limitation is the reliance of self-
report in public venues when private settings could not be
provided. Participants may have under-reported risk
behavior during the assessment. The FRA was very limited
in the variables it collected because it was designed to be
used for initial encounters in the field. It did not collect
income, education, and history of previous vaccination.
In light of the results of the current study, the authors
advocate that public health efforts take a comprehensive
approach to targeting high-risk MSM for HAV and HBV
vaccination. Because of the demonstrated success of
vaccinating MSM at Gay Pride events, it is crucial that
the opportunities afforded by these venues be exploited for
public health benefit. However, it is equally important that
224 Prev Sci (2010) 11:219–227no-cost vaccinations be funded in various other community
venues such as STI clinics, drug treatment programs,
prisons, universities, and other community resource centers.
With adequate funding for community no-cost vaccination,
including the continued efforts of vaccinating at Gay Pride
events, the eradication of both HAV and HBV in the U.S.
may soon become a reality.
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